Outsourced healthcare services provider Ashfield, part of UDG Healthcare, has announced the launch of an agile, multi-channel engagement model underpinned by a field analytics engine to address the challenges of pharmaceutical companies needing to maintain or improve return on investment (ROI). Utilizing the AshfieldGuide, a sales analytics and planning platform, The Ashfield Solution is said to provide a more efficient, impactful and agile sales model with the capability to flex resources in "real-time" in reaction to market events.
The new model helps pharmaceutical companies optimize their investment in light of margin pressure, loss of exclusivity, new product data and new market entrants including biosimilars. It reportedly provides advanced analytics capabilities in response to curve modeling, segmentation techniques, mix modeling and geospatial optimization. In addition, the commercial model delivers engagement optimization and monthly reporting on ROI, call attainment and performance.
For more information, visit
